Vanguard Group Discloses Position in Mural Oncology plc

The Vanguard Group, Inc. recently filed Form 8.3 with the Irish Takeover Panel, revealing its interests in Mural Oncology plc. As per the disclosure dated August 1, 2025, Vanguard controls 772,371 ordinary shares of Mural Oncology, representing 4.47% of the company's securities.

The filing also notes recent dealings by Vanguard, which acquired 32 additional shares at a price of 2.32 USD each. This transaction underlines an active stake, though no short positions or additional financial instruments were reported.

No agreements regarding options or derivatives, nor any indemnities relating to these securities, were declared. Furthermore, there are no attachments or further details offered in the Supplemental Form 8. This disclosure provides transparency into Vanguard's current involvement with Mural Oncology, a crucial element in public company transactions.